Evolus, Inc.
EOLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001570562
In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Evolus, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 137
- +2 vs. Q2 2023
- Shares held
- 41.4M
- +4.17M (+11.2%) vs. Q2 2023
- Total value
- $378.8M
- +$107.7M (+39.7%) vs. Q2 2023
- New holders
- 15
- 63 more added
- Sold out
- 13
- 33 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EOLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 158 | $335.1M |
| Q1 2026 | 147 | $188.3M |
| Q4 2025 | 169 | $327.3M |
| Q3 2025 | 160 | $334.4M |
| Q2 2025 | 172 | $538.8M |
| Q1 2025 | 179 | $652.9M |
| Q4 2024 | 164 | $573.1M |
| Q3 2024 | 165 | $814.5M |
| Q2 2024 | 156 | $557.1M |
| Q1 2024 | 164 | $691.0M |
| Q4 2023 | 151 | $479.6M |
| Q3 2023 | 137 | $378.8M |
| Q2 2023 | 135 | $271.1M |
| Q1 2023 | 126 | $288.7M |
| Q4 2022 | 120 | $219.8M |
| Q3 2022 | 130 | $205.7M |
| Q2 2022 | 123 | $294.2M |
| Q1 2022 | 118 | $266.3M |
| Q4 2021 | 104 | $133.1M |
| Q3 2021 | 113 | $134.9M |
| Q2 2021 | 115 | $205.3M |
| Q1 2021 | 96 | $111.8M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Evolus, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janney Montgomery Scott LLC | 11,600 | $106.0K | 0.00% | 00.0% | Unchanged |
| Private Trust Co NA | 11,558 | $105.6K | 0.01% | 00.0% | Unchanged |
| Cetera Advisors LLC | 11,477 | $104.9K | 0.00% | +185+1.6% | Added |
| Gsa Capital Partners LLP | 11,026 | $101.0K | 0.01% | −87,352−88.8% | Reduced |
| Commonwealth Equity Services, LLC | 10,800 | $99.0K | 0.00% | 00.0% | Unchanged |
| Nebula Research & Development LLC | 10,475 | $95.7K | 0.05% | +10,475 | New |
| Qube Research & Technologies Ltd | 9,832 | $89.9K | 0.00% | −1,165−10.6% | Reduced |
| Quantbot Technologies LP | 8,400 | $76.8K | 0.01% | +452+5.7% | Added |
| Global Retirement Partners, LLC | 8,650 | $72.9K | 0.00% | +7,775+888.6% | Added |
| Amalgamated Bank | 5,966 | $55.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 5,970 | $54.6K | 0.00% | −8,402−58.5% | Reduced |
| Royal Bank of Canada | 5,897 | $53.0K | 0.00% | +2,617+79.8% | Added |
| Nisa Investment Advisors, LLC | 5,767 | $52.7K | 0.00% | 00.0% | Unchanged |
| Tradition Wealth Management, LLC | 5,525 | $50.0K | 0.01% | +5,525 | New |
| Point72 Middle East FZE | 5,219 | $47.7K | 0.00% | +5,219 | New |
| Washington Trust Co | 5,000 | $45.7K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 4,084 | $37.3K | 0.00% | +1,555+61.5% | Added |
| Advisor Group Holdings, Inc. | 3,965 | $36.2K | 0.00% | +2,000+101.8% | Added |
| Bank of Montreal | 2,616 | $24.7K | 0.00% | −10.0% | Reduced |
| Metropolitan Life Insurance Co | 2,418 | $22.1K | 0.00% | +461+23.6% | Added |
| FMR LLC | 1,831 | $16.7K | 0.00% | −781−29.9% | Reduced |
| Great West Life Assurance Co | 1,731 | $16.0K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 1,459 | $13.3K | 0.00% | +713+95.6% | Added |
| Plante Moran Financial Advisors, LLC | 1,220 | $11.2K | 0.00% | −954−43.9% | Reduced |
| IAG Wealth Partners, LLC | 927 | $8.47K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 850 | $7.77K | 0.00% | −750−46.9% | Reduced |
| US Bancorp | 688 | $6.29K | 0.00% | 00.0% | Unchanged |
| Aquatic Capital Management LLC | 600 | $5.00K | 0.00% | −10,600−94.6% | Reduced |
| CWM, LLC | 533 | $5.00K | 0.00% | +83+18.4% | Added |
| Halpern Financial, Inc. | 500 | $4.57K | 0.00% | 00.0% | Unchanged |
| Stephens Consulting, LLC | 290 | $2.65K | 0.00% | 00.0% | Unchanged |
| Quadrant Capital Group LLC | 228 | $2.08K | 0.00% | +228 | New |
| Proequities, Inc. | 154 | $1.41K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 162 | $1.00K | 0.00% | 00.0% | Unchanged |
| GHP Investment Advisors, Inc. | 80 | $652 | 0.00% | +80 | New |
| Huntington National Bank | 1 | $9 | 0.00% | 00.0% | Unchanged |
| VitalStone Financial, LLC | 30 | $0 | 0.00% | 00.0% | Unchanged |
| Eversept Partners, LP | 0 | $0 | 0.00% | −228,679−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −203,283−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −84,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −53,921−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −25,369−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −16,122−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,962−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −12,039−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −10,034−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |